Characterization of HIV drug resistance mutations and subtype diversity of isolates from children and adolescents failing viral suppression in Kenyatta National Hospital

International Workshop on HIV & Adolescence 2019

Transitioning from post-exposure prophylaxis to pre-exposure prophylaxis among transgender women in the Tangerine Community Health Center in Bangkok, Thailand

APACC 2019

Dolutegravir plus Tenofovir Disoproxil Fumarate/ Emtricitabine as HIV post-exposure prophylaxis: efficacy and safety results from real world study

APACC 2019

Implementing Physiotherapy in an HIV Community-Based Care Setting: A Qualitative Study of Perspectives From People Aging With HIV and Health Care Providers

International Workshop on HIV & Aging 2020

A same day screen, test and treat model for chronic HCV and HBV infection: Results from two community-based pilot studies

Conference on Liver Disease in Africa (COLDA) 2019

(Abstract) HIV-1 group O infection in Cameroon from 2006 to 2013: prevalence, genetic diversity, evolution and public health challenges | A.F. Aghokeng

INTEREST 2016

Caregiver HIV Status Disclosure associated risk of distress, anxiety and depressive symptoms in dependent 8 – 18 years old children from Uganda

International Workshop on HIV & Adolescence 2021

“Who am I going to stay with? Who will accept me?” – A qualitative study of family-level factors underlying disengagement from HIV care among Kenyan adolescents

International Workshop on HIV Pediatrics 2021

Management of Toxicities from Immunotherapy: an ESMO Clinical Practice Guideline | Caroline O'Leary, BA (Hons), MSc (LSE), MB BCh BAO (Hons), MRCPI

Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy

Resistance mutations to different classes of antiretroviral agents predict virological failure in HIV+ patients with low level viremia: a retrospective study from the ARCA cohort- Francesca Lombardi

European Meeting on HIV & Hepatitis 2018